Known risk factors can show significant heterogeneity in their association with prostate cancer development. However, the identification and further characterization of risk modifiers might ...
Syed Arsalan Ahmed Naqvi et al, The Promise and Challenges of Genomic Classifiers in Localized Prostate Cancer, Annals of Internal Medicine (2025). DOI: 10.7326/ANNALS-24-03630 Journal information ...
Hosted on MSN3mon
Why some prostate cancers shouldn't be called 'cancer'and this huge heterogeneity exists within the spectrum of prostate cancers as well. We've made huge progress in understanding prostate cancer's typical progression in people. We've grown quite ...
Tests do not consistently influence risk classification or treatment decisions; authors call for well-designed trials on role of GC tests in newly diagnosed PCa. (HealthDay News) — For patients ...
Hosted on MSN28d
Genomic Classifier Tests Play Heterogeneous Role in Prostate Cancer Risk ClassificationTUESDAY, Jan. 21, 2025 (HealthDay News) -- For patients with localized prostate cancer (PCa), tissue-based genomic classifiers (GCs) do not consistently influence risk classification or treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback